You searched for "neovascular"
Sharing best practice and landmark evidence in glaucoma care
Evolving technology, best practice and landmark evidence in glaucoma care were reviewed by an international expert faculty in session presentations and debates during the 11th Moorfields International Glaucoma Symposium 2019. The authors were meeting chairs and provide an overview of...Update on emerging therapies for age-related macular degeneration
4 December 2023
| Rod McNeil
|
EYE - Vitreo-Retinal
The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...
Third nerve palsy
1 August 2017
|
EYE - Neuro-ophthalmology, EYE - General
Case scenarios A 71-year-old female presented to a nearby eye emergency unit with two days history of partial ptosis in her left eye with diplopia. She saw her GP earlier that day and he asked her to go to the...
Analysis and outcome of explanted hydroxyapatite orbital implants
This is a retrospective case series over 11 years of 25 patients with exposed synthetic hydroxyapatite orbital implants who underwent explantation and simultaneous replacement with a dermis fat graft. All patients had signs of infection and had been treated with...
OCT angiography metrics in children
3 June 2021
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
This prospective study aimed to quantify the vessel density of both the macular and optic nerve and foveal avascular zone (FAZ) values in 92 normal eyes of 92 children (42 boys, 50 girls) aged 13.4 ±2.65 years (seven to 18)....
25 years of OCT
David Huang first described optical coherence tomography (OCT) in 1991, in his seminal paper on the subject in Science. This method developed the work of others on ophthalmic interferometry, which essentially showed that measuring reflected light could be used to...Headaches in ophthalmology (part 1)
Ophthalmologists see a large number of patients with headaches or facial pain in the ophthalmic outpatient clinics or in emergency clinics. Over two articles, I will discuss several causes of headaches, ocular manifestations and proposed management and referral options. It...Haag-Streit announces “Slit Lamp Imaging Competition 2024” winners
18 October 2024
|
opportunities, slit lamp, imaging, competition, awards, haag-streit, SLIC2024, 2024
Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is pleased to announce the results of Haag-Streit's 'Slit Lamp Imaging Competition 2024'. Utpal Sarkar, from Disha Eye Hospitals,...
Licence to save: a UK survey of anti-VEGF use for the eye
1 February 2017
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...
Corporate M&A pace gathers momentum
1 October 2019
| Rod McNeil
|
EYE - General
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...
Belfast briefing: Retina Day roundup from the RCOphth 2024 Annual Congress
2 August 2024
| Rod McNeil
|
EYE - General
Belfast hosted this year’s Royal College of Ophthalmologists’ (RCOphth) Annual Congress, a meeting dedicated to sharing advances, knowledge and clinical practice points in ophthalmic care. This article summarises selected talks by medical and surgical retina specialists during the Retina Subspecialty...
Eye Capacity: clinical need should drive ophthalmic service provision
1 February 2014
| Rod McNeil
Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...
